High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsThe antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.Extended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human fecal carriers of ESBL-producing Enterobacteriaceae.The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.Fecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study.The implications of antibiotic resistance for patients' recovery from common infections in the community: a systematic review and meta-analysis.Antimicrobial susceptibility of uropathogens isolated from Cambodian children.Role of old antimicrobial agents in the management of urinary tract infection.Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production.The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location.Noncarbapenem ß-Lactams for the Treatment of Extended-Spectrum ß-Lactamase Infections: What Are the Remaining Drugs Outside the United States?In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase.Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review.
P2860
Q21131083-7DA78D06-A246-42B8-B203-7E80C5AD6948Q30379659-7697B3F2-D674-4CBC-BF45-C11FDA589F17Q34079113-3189032C-A3B2-466D-AE61-E3D9C078DC03Q36209009-F910D49F-47D4-45F1-9E34-7093A31888E0Q36299441-96088AAF-461B-474A-BCA5-AC9236F36988Q36332161-0A28EFA9-424D-4245-AF56-C92B70AEB685Q37704754-E7E3AA6E-47FA-4905-861B-EA8B0B5EF07FQ38832723-4A52FDE0-46A3-47F4-A82A-72922A4F049AQ40967518-63304882-2173-4299-9C48-F6605F4F72B8Q42210504-D16618BD-AAC7-48FA-9CBE-CB7E2A3325EDQ42685344-F2F21658-0780-4C6E-8C92-C92FB0F217BAQ50094170-611667CD-63EB-46F6-84E6-704577B01DDFQ54287513-CEBD4019-A737-443F-A3D1-51280831E711Q55113256-0FBE537A-1986-46B8-B62D-AB8B24C62EF5
P2860
High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High rate of per oral mecillin ...... BL-producing Escherichia coli.
@en
High rate of per oral mecillin ...... BL-producing Escherichia coli.
@nl
type
label
High rate of per oral mecillin ...... BL-producing Escherichia coli.
@en
High rate of per oral mecillin ...... BL-producing Escherichia coli.
@nl
prefLabel
High rate of per oral mecillin ...... BL-producing Escherichia coli.
@en
High rate of per oral mecillin ...... BL-producing Escherichia coli.
@nl
P2860
P50
P1433
P1476
High rate of per oral mecillin ...... BL-producing Escherichia coli.
@en
P2093
Arne Søraas
Pål A Jenum
P2860
P304
P356
10.1371/JOURNAL.PONE.0085889
P407
P577
2014-01-15T00:00:00Z